Overview

Dysfunctional voiding (DY) is one of the most common conditions in children. Various treatments are available. Participants will be randomly assigned to either PTCE (Group I) or PTCE+DNS (Group II). PTCE is the gold standard and routinely administered in hospitals for children diagnosed with dysfunctional voiding who are referred by a urologist. The PTCE group serves as the control group, and treatment will be scheduled for a total of 10 weeks, two days a week. During PTCE, children receive instruction about the pelvic floor using video visuals and increase awareness of their pelvic floor muscles. They are then instructed on how to contract and relax their muscles to control urination. DNS training is an exercise model that begins with spinal stabilization and addresses muscle synergies. Patients included in the study will be evaluated twice, at the beginning and at the end of the treatment, with the Voiding Disorders Symptom Score (VODS), Quality of Life Scale for Children with Urinary Incontinence (QOLS), Bladder Bowel Dysfunction Scale (BDS), Bristol Stool Scale and Children's Body Image Scale.

Eligibility

Inclusion Criteria:

• Having been diagnosed with voiding dysfunction according to ICCS diagnostic criteria in a urology outpatient clinic,
• Being 5-18 years old,
• The child and their parent/guardian agree to participate in the study voluntarily and provide signed consent.

Exclusion Criteria:

• Organic pathologies such as urethral obstruction, ectopic ureter, spinal dysraphism, and diabetes
• Diagnosis of VUR or neurogenic bladder
• Cognitive and mental impairment
• Having spina bifida
• Being under 5 years of age
• Receiving treatment such as PTC training or electrical stimulation